EPX-103

N/A

Report date: 2024/04/01 14:20:57
NME

Base Information

Drug NameEPX-103
Drug Alias NameEPX-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor modulatorsHistamine H1 receptor antagonists
TargetsSerotonin (5-HT) receptorHistamine H1 receptor
Therapy Area/IndicationsBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpygenix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpygenix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A